A detailed history of Al Ti Global, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Al Ti Global, Inc. holds 2,751 shares of MRNA stock, worth $325,498. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,751
Previous 2,751 -0.0%
Holding current value
$325,498
Previous $274 Million 7.15%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $191,222 - $287,286
2,751 New
2,751 $274 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $46.3B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Al Ti Global, Inc. Portfolio

Follow Al Ti Global, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Al Ti Global, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Al Ti Global, Inc. with notifications on news.